Comparative Pharmacology
Head-to-head clinical analysis: DERMABET versus FLUTEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DERMABET versus FLUTEX.
DERMABET vs FLUTEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Betamethasone dipropionate is a corticosteroid that diffuses across cell membranes and binds to glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. It induces phospholipase A2 inhibitory proteins (lipocortins), thereby inhibiting the release of arachidonic acid and decreasing the synthesis of prostaglandins and leukotrienes. This results in anti-inflammatory, antipruritic, and vasoconstrictive effects.
Flutamide is a nonsteroidal antiandrogen that competitively inhibits the binding of dihydrotestosterone (DHT) to androgen receptors in target tissues, thereby blocking the androgenic effects.
Apply a thin layer to affected area once or twice daily. Maximum 50 g per week.
50 mg orally once daily
None Documented
None Documented
Terminal elimination half-life: 3-4 hours; prolonged in hepatic impairment
Terminal elimination half-life: 24–36 hours, permitting once-daily dosing in chronic therapy
Renal (60-70% as unchanged drug and metabolites), biliary/fecal (30-40%)
Renal: ~70% (50% unchanged, 20% as metabolites); Biliary/fecal: ~30%
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid